Multiple Testing Correction with Repeated Correlated Outcomes: Applications to Epigenetics by Leap, Katie
University of Massachusetts Amherst 
ScholarWorks@UMass Amherst 
Masters Theses Dissertations and Theses 
October 2017 
Multiple Testing Correction with Repeated Correlated Outcomes: 
Applications to Epigenetics 
Katie Leap 
University of Massachusetts Amherst 
Follow this and additional works at: https://scholarworks.umass.edu/masters_theses_2 
 Part of the Bioinformatics Commons, Biostatistics Commons, Computational Biology Commons, and 
the Longitudinal Data Analysis and Time Series Commons 
Recommended Citation 
Leap, Katie, "Multiple Testing Correction with Repeated Correlated Outcomes: Applications to Epigenetics" 
(2017). Masters Theses. 559. 
https://scholarworks.umass.edu/masters_theses_2/559 
This Open Access Thesis is brought to you for free and open access by the Dissertations and Theses at 
ScholarWorks@UMass Amherst. It has been accepted for inclusion in Masters Theses by an authorized 
administrator of ScholarWorks@UMass Amherst. For more information, please contact 
scholarworks@library.umass.edu. 
Multiple Testing Correction with Repeated Correlated Outcomes:  
Applications to Epigenetics 
 
 
A Thesis Presented 
by 
KATRINA N. LEAP 
 
 
Submitted to the Graduate School of the 
University of Massachusetts Amherst in partial fulfillment 
of the requirements for the degree of 
 
MASTER OF SCIENCE 
 
September 2017 
 
Public Health 
Biostatistics  
Multiple Testing Correction with Repeated Correlated Outcomes:  
Applications to Epigenetics 
 
A Thesis Presented 
by 
KATRINA N. LEAP 
 
Approved as to style and content by: 
 
 
Kenneth P. Kleinman, Chair 
 
 
Brian W. Whitcomb, Member 
 
 
Matthias Steinrücken, Member 
 
 
Susan E. Hankinson, Department Head 
Department of Biostatistics & Epidemiology 
 iii 
ACKNOWLEDGEMENTS 
 
I would first like to thank my advisor and thesis chair, Ken Kleinman, ScD, for bringing 
this project to my attention and always having my research interests in mind, even if they 
bore him to death. I am so grateful for his consistent guidance and lenient deadlines; the 
combination of the two has enabled this work to be completed. 
I would like to thank all of my collaborators: Marie-France Hivert and Andres Cardenas 
for their insight into underlying epigenetic mechanisms and the proper framework to think 
about this problem; Sam Lent for coming up with the research question that prompted this 
study; Cat Briggs for her tireless data analysis and for coming into work on the weekend to 
get this done in time; Tim Adams for his help in optimizing the data generation code and 
saving me months of computational time. 
I would also like to thank my committee members Brian Whitcomb and Matthias 
Steinrücken for their timely help shaping my approach at the beginning and refining the 
details at the end, and for their patience through the lack of updates in the middle. 
Lastly I would like to thank my friends and family. Thank you for listening to me rant 
about the cluster, for persevering through math explanations of any length that did not 
interest you, for overlooking my constantly divided attention, and for asking the questions I 
forget to ask. A special shout out to Brook Frye, Justin Baldwin, and Mahim Naveed for help 
with my code and sanity; to Jess Buske for making sure my housework was attended to at 
least every other month; and to Sarah Murcek, Meghan Weakley, and Rebekah Whittier for 
sticking with me through the ups and downs and reminding me of all the jokes that matter. 
  
 iv 
ABSTRACT 
MULTIPLE TESTING CORRECTION WITH REPEATED CORRELATED OUTCOMES:  
APPLICATIONS TO EPIGENETICS 
SEPTEMBER 2017 
KATRINA N. LEAP, B.I.A., CHATHAM UNIVERSITY 
M.S., UNIVERSITY OF MASSACHUSETTS AMHERST 
Directed by: Professor Kenneth P. Kleinman 
Epigenetic changes (specifically DNA methylation) have been associated with adverse 
health outcomes; however, unlike genetic markers that are fixed over the lifetime of an 
individual, methylation can change. Given that there are a large number of methylation sites, 
measuring them repeatedly introduces multiple testing problems beyond those that exist in 
a static genetic context. Using simulations of epigenetic data, we considered different 
methods of controlling the false discovery rate. We considered several underlying 
associations between an exposure and methylation over time. 
We found that testing each site with a linear mixed effects model and then controlling 
the false discovery rate (FDR) had the highest positive predictive value (PPV), a low number 
of false positives, and was able to differentiate between differential methylation that was 
present at only one time point vs. a persistent relationship. In contrast, methods that 
controlled FDR at a single time point and ad hoc methods tended to have lower PPV, more 
false positives, and/or were unable to differentiate these conditions. 
Validation in data obtained from Project Viva found a difference between fitting 
longitudinal models only to sites significant at one time point and fitting all sites 
longitudinally.   
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CHAPTER 1 
INTRODUCTION 
Epigenetic processes regulate how genes are expressed without changing the genetic 
sequence; DNA methylation is a mechanism that can turn a gene on or off and has been 
implicated in many diseases (Jirtle & Skinner, 2007). Although the genetic sequence of an 
individual is identical in all cells and stable over their lifetime, epigenetic markers like 
methylation are vital to cell differentiation and thus vary from cell to cell (Franchini, 
Schmitz, & Petersen-Mahrt, 2012). Monozygotic twin studies have shown cross-sectionally 
that while younger twin pairs have identical methylation patterns, the patterns of older twins 
diverge, indicating that methylation changes over time (Fraga, et al., 2005). Previous studies 
have examined the relationship between early exposures and site-specific differential 
methylation in a cross-sectional manner and some have studied global methylation levels 
within-person over time, but the effect of early exposures on site-specific methylation later 
in life is poorly understood.  
Although epigenetic methods draw heavily on those used for genome-wide association 
studies (GWAS), the changeable nature of epigenetic markers necessitates methods that 
draw from longitudinal analysis. Despite using similar methods, genetic and epigenetic data 
differ in a few key ways. Genetic loci can consist of one of four nucleotides, but methylation 
is a binary indicator. With GWAS data, the many genetic loci are considered to be predictors 
of an outcome, but with epigenetic data, methylation status is considered the outcome and 
the disease status or exposure is the predictor. While multiple testing correction for genetic 
applications can be addressed by controlling the Benjamini-Hochberg False Discovery Rate 
(FDR) for multiple tests of association, epigenetic data introduces a longitudinal aspect 
previously unexplored. Furthermore, it is highly unlikely that methylation status at any 
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point is independent of its previous status and we would expect that it would be correlated 
over time within-person.  
Our purpose in this article is to explore multiple approaches to this problem and evaluate 
them using simulation studies and then apply them to a particular research question 
motivated by Project Viva, a prospective cohort study established to study the effect of 
prenatal diet on maternal and child health well-documented elsewhere (Oken, et al., 2015). 
Because of the correlation structure within-person over time, we use a linear mixed effects 
model to detect associations between an exposure and a large number of outcomes: 
methylation at each site. However, this approach is computationally expensive, so we will 
explore methods to decrease the number of such models that need to be fit. Methods will be 
evaluated based on whether they can detect whether associations persist over time and 
whether they can control the FDR adequately. 
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CHAPTER 2 
BACKGROUND 
For the purposes of this analysis, we are considering the longitudinal relationship 
between a single point exposure and multiple outcomes. Each individual has one exposure 
measure regardless of how many outcomes are measured. The outcomes are site-specific 
methylation at ! different time points. At each observation time, there are " measured sites. 
Thus we can consider each site at each time point individually, allowing for "	×	! possible 
associations, or we can construct a longitudinal model of the " sites, generating " 
associations. 
Methylation 
Methylation refers to the addition of a methyl group (CH3) to cytosine, one of the amino 
acids in DNA; methylation status is therefore binary: either the cytosine has a methyl group 
or it does not. However, methylation is not typically assessed on single cells, but rather on a 
mixture of cells. Because of this, methylation outcomes represent a proportion of cells in the 
sample that are methylated at any given site; these methylation levels are Beta-distributed 
and termed Beta-values (Du, et al., 2010). As the Beta-values will be heteroscedastic, or 
having a non-constant variance, we can transform them to M-values, defined as "% =log* +,-./01+,-./  (Du, et al., 2010). In addition to addressing the issue of constant variance, this 
transformation means that the values are no longer bounded between 0 and 1, which makes 
them more suited for analysis with linear models. 
Methylation over time 
Previous studies have been done on global methylation within-person over time. One 
study compared cord blood to blood collected at 3 years in 165 children and found that while 
on average, methylation was higher in the second time point, within-person differences were 
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lower. Furthermore, 62% of individuals’ methylation changed very little, 12% decreased and 
27% increased (Herbstman, et al., 2013). Another study of 77 adults comparing blood draws 
an average of 8 years apart found that about a third had large changes in global methylation 
(≥ 10%); 19.5% were increases and 13.0% were decreases (Wu, Wang, Delgado-Cruzata, 
Santella, & Terry, 2012). A third study examined longitudinal global methylation changes 
within-individuals clustered by families; in one of their cohorts, 30% had a ≥10% change in 
methylation over time and the other cohort had 18%. Additionally, they found a familial 
clustering effect on methylation changes (Bjornsson, et al., 2008).  
A study similar to the one motivating this one examined the effect of both birth weight 
and gestational age on longitudinal site-specific DNA methylation. They used cord blood as 
their first time point and followed up at age 7 and 17; their statistical analysis consisted of 
identifying sites associated with the predictor in the first time point and conducting 
longitudinal analysis of only those sites (Simpkin, et al., 2015). 
Linear mixed effects models 
In order to account for correlation within individuals and to evaluate the effect of time 
on the relationship between a predictor and a repeated outcome, we can use a linear mixed 
effects (LME) model. While linear regression forces a common intercept and slope for all 
individuals, mixed effects models allow individuals to have different random intercepts 
and/or slopes. This means that while the effect of the predictor may be similar across 
individuals, some individuals start with a higher or lower baseline and can have an 
individual deviance from the effect of the predictor. We use the lme4 package in R to fit 
LME models for the simulation studies (Bates, Maechler, Bolker, & Walker, 2015) and 
robustlmm for the applied analysis (Koller, 2016). 
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Controlling the false discovery rate 
The False Discovery Rate (FDR) was defined by Benjamini and Hochberg in 1995 in 
terms of the following variables: 
Table 1: Relationship between m0 and R 
 Declared  Non-Significant 
Declared 
Significant Total 
True Null 
Hypotheses U V m0 
Non-True Null 
Hypotheses T S m – m0 
 m - R R m 
 
m represents the null hypotheses being tested simultaneously; in our setting, m is 
470,870 or the number of sites for which we have methylation outcomes. R is observable 
and represents all of the sites that our method returns as significantly associated with the 
predictor, but all of the other variables are not observable. The rate at which we make false 
discoveries is 2 = 34, where V is our Type I error. 
The method for controlling the FDR is an algorithm that orders the p-values found by 
the test of the null hypothesis and then compares them iteratively to a function of the rank of 
the p-value and the desired controlled FDR value. More details can be found in the paper, 
but important to note is that this procedure rejects null hypotheses based on both the 
number of hypotheses there are total and their ordered values; it does not adjust the p-
values as a Bonferroni correction would (Benjamini & Hochberg, 1995). However, we use the 
p.adjust function in R, which changes the p-value to the q-value and allows us to filter the 
sites as we might if the p-values had been adjusted (R Core Team, 2017). 
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Motivating example: Project Viva 
Our study was motivated by an analysis of the effect of maternal glucose levels on a 
child’s DNA methylation, as a hypothesized mechanism of the observed relationship 
between a mother’s gestational diabetes mellitus and the risk of obesity, cardiovascular 
disease, and type 2 diabetes later in the child’s life. To this end, exclusion criteria included 
mothers with diagnosed diabetes, as well as those who were underweight, premature births, 
and non-white children. Glucose was measured as non-fasting 50-gram glucose challenge 
test in trimester 2. 
Preliminary analysis showed a relationship between the maternal glucose and 
methylation status at the first time point at different locations, but it is unknown whether 
these relationships continue over time. Methylation was assessed using the Illumina 450k 
Assay: there are about 470,870 locations measured. There are 660 observations on 430 
children over three time points: in the cord blood, in early childhood (~ 3 years old) and in 
mid-childhood (~ 7 years old). 
Plausible underlying associations 
The longitudinal relationship between exposure and outcome could take on several 
different shapes. In order to assess the methods' abilities to detect underlying associations, 
we considered four different plausible patterns of association over time: null association, 
constant association, attenuated association, and acute association. These will be defined 
more formally in the methods section. 
Behavior of persistent associations 
As mentioned briefly already, a key component of this analysis is whether differential 
methylation persists over time. This has implications for interventions: if differential 
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methylation at sites associated with disease later in life corrects itself within a finite time 
frame after exposure, it is unlikely that an intervention targeting the exposure would be 
worthwhile. Therefore, we do not want our method to identify sites that are correlated at the 
first time point, but do not have a persistent correlation.  
Additionally, we want to distinguish this behavior from an attenuated relationship, 
especially given that we might expect the association to attenuate if the cells are able to 
restore the original methylation after exposure. We want to detect a difference between 
complete restoration and a weakened association over time. 
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CHAPTER 3 
METHODS 
Simulations were used to investigate differences between our three proposed methods of 
correcting for multiple testing. All three of the methods use the Benjamini-Hochberg False 
Discovery Rate, but vary when in the process rejections are made. For all methods, data was 
first generated according to one of four underlying assumptions. Then sites thought to be 
significantly associated with the exposure were identified.  
The first method uses a pairwise correlation test to identify sites, corrects for multiple 
testing, and then tests whether the correlation persists over time in the selected sites with a 
linear mixed effects model. We call this method an FDR method because FDR is used to 
select a subset of sites to fit to an LME. This method is similar to the one used in the study of 
gestational age and birth weight (Simpkin, et al., 2015).  
The second method uses a pairwise correlation test to identify sites, tests whether the 
correlation persists over time in a subset of these sites with a linear mixed effects model, and 
then corrects for multiple testing. We call this method a rank method because ranked p-
values are used to select a subset of sites to fit to an LME. We arbitrarily chose 1000 as the 
size of the subset and select the 1000 lowest p-values. 
The third method uses a linear mixed effects model to both identify sites and test 
whether the correlation persists over time and corrects for multiple testing. We call this 
method All LME because all sites are selected to fit to an LME. 
Because the data is simulated, we then calculated the percentage of the true associations 
found, as well as a measure of the false associations. Correlation is calculated using the cor 
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function in R and is Pearson’s correlation coefficient (R Core Team, 2017), but any test of 
correlation could have been used. 
Our general method is as follows: 
1. Generate a data set according to a specified data generating method 
2. Run pairwise correlation tests between the predictor and the outcomes 
3. Select sites that pass selection criteria 
4. Fit an LME to each of the selected sites 
5. Return the sites that achieve a significance threshold 
For each of our four data generating assumptions, we repeated this process 1000 times. 
The All LME method omits steps 2 and 3. 
Data generating assumptions 
For all of our data generation, we used a continuous predictor simulated from a standard 
normal distribution. We then simulated methylation status outcomes as continuous 
variables for 300 individuals at 3 time points according to the linear relationships described 
below. These values are not bounded by 0 and 1 because their analogue is an M-value rather 
than a Beta-value. We have a total of 470,560 sites in the simulation study: 470,000 
locations have no association with the predictor; 500 have a weak association; 50 have a 
moderate association; and 10 have a strong association. These numbers were chosen based 
on estimates provided by our collaborators at the Harvard Medical School Department of 
Population Medicine. 
We calibrated the actual values for these strengths of association by varying the three 
different effect sizes while generating simulated data sets and measuring the percentage 
achieving a significance of p < 0.05 after FDR correction on a Pearson's correlation test on 
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just the first time point, averaged over 1000 replicates. We chose the effect sizes that 
resulted in:  
• Weak association: about 10% of 500 locations achieved significance 
• Moderate association: about 50% of 50 locations achieved significance 
• Strong association: just under 100% of 10 locations achieved significance 
For this simulation, the effect sizes were 0.1753, 0.2483, and 0.4089 respectively, but 
these have no real world analogue. 
Because of the computational expense, raw data was not simulated for the 470,000 
uncorrelated sites. Raw data was simulated for the 560 truly associated locations, from 
which p-values were calculated, while simulated p-values (from a uniform distribution) were 
used for the 470,000 uncorrelated sites. If one of the uncorrelated locations was selected 
spuriously and therefore needed to be fit to an LME, a bootstrap method was employed to 
select an effect size to use to generate correlated data.  
Null 
The first possible relationship between the exposure and outcomes is that of no 
relationship. This means that the exposure and outcomes are independent of each other. 
Each site's methylation is constant, except for measurement error, and is not associated with 
the exposure. Measurement error refers both to our inability to measure methylation 
perfectly and our lack of knowledge about the behavior of methylation over time. 
Under the assumption of no relationship, the outcome is simulated independently of the 
simulated predictor for the 560 sites. In the following equation, 5 is the continuous 
methylation outcome over three indices: the location 6 = 1… 470,560; the individual ?	 =	1… 300; and the time point A = 1, 2, 3. 
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5C,%- = 	 DC,% + FC,%- (1) 
For each location, the equation describes a linear mixed effects model with fixed 
intercept of 0 and a random intercept. There are two error terms: DC,% ∼ H(0,0.05) and FC,%- ∼H(0,0.95), where H(M, N*) denotes a normal distribution with mean M and variance N*. The 
first error term is shared between the three time points within an individual and the second 
is simulated independently for every time point. Therefore, even though there is no 
relationship between the predictor and the outcome, the three time points are correlated 
within-individual.  
Constant 
The next possible relationship is that the exposure influences the outcome in a constant 
manner. For example, a person with a higher level of exposure would have a higher 
methylation outcome and this relationship would be constant over time. Because the 
exposure is fixed, this means that the methylation status would be fixed over time, except for 
measurement error. This is a fairly simplistic model, but if the data followed this pattern, it 
would have large implications for possible interventions.  
Under the assumption of a constant relationship, the outcome is simulated using the 
simulated exposure, denoted here as O% ∼ H(0,1), as mentioned in the Data generating 
assumptions section. The effect of the predictor on the outcome is denoted as PC because it is 
dependent on the location. It is simulated as three distinct values, representing strong, 
moderate or weak associations, but we would expect each PC to be unique. We simulate 10 
strongly associated sites, 50 moderately associated, and 500 weakly associated. 
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PC = 	 00.17530.24830.4089									
6 ≤ 470,000470,000 < 6 ≤ 470,500470,500 < 6 ≤ 470,5506 > 470,550 	 (2) 
5C,%- = 	PCO% + DC,% + FC,%-  (3) 
Note that for 6 < 470,000, there is no association between O and 5C. The error terms in 
(3) are simulated as in (1). Here we can index on time, but it is not featured in the equation. 
Attenuated 
It is possible that the exposure influences the outcome in a linear manner as described 
above, but that the strength of the relationship decreases over time. This is a more likely 
model than stable levels of methylation over time, given that methylation changes over time.  
Under the assumption of a linear relationship that attenuates, the outcome is simulated 
using the simulated exposure and a time-dependent factor. At the first time point, the 
predictor is the same as in the constant relationship. At the second time point, the P term is 
multiplied by 0.8. At the third time point, the P term is multiplied by 0.6. We represent the 
different relationships with an indicator function, denoted U(V), where U V = 	1 if V is true 
and 0 otherwise. 
PC is defined as in (PC = 	 00.17530.24830.4089									
6 ≤ 470,000470,000 < 6 ≤ 470,500470,500 < 6 ≤ 470,5506 > 470,550 	 (2). 
5C,%- = 	PCO%	U A = 1 +	PCO%		U A = 2 	×	0.8 + PCO%	U A = 3 ×	0.6 + DC,% + FC,%- (4) 
The error terms in (4) are simulated as in (1). 
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Acute 
The final relationship we considered was that the exposure influences the outcome in the 
time point closest to it, but it is not associated at later time points. This is another 
biologically plausible relationship, in which a sudden event affects the methylation for only a 
short period. 
Under the assumption of an acute relationship, the outcome at the first time point is 
simulated as in the constant relationship, but the outcomes at the second and third time 
points are simulated as in the null relationship. The indicator function is denoted again U(V). 
PC is defined as in (2). 
5C,%- = 	PCO%	U A = 1 +	DC,% + FC,%- (5) 
The error terms in (5) are simulated as in (1). 
Multiple testing correction 
Although the previous study used just the cord blood correlations to select sites to fit an 
LME model to, we consider different selection methods because there might be differences 
between the time points in terms of their relationship with the predictor. For example, if the 
relationship is constant, we lose power by only considering the first time point. We consider 
three different ways of applying our two-step methods, FDR or rank, each based on a 
pairwise correlation test. 
The LME model that we fit was the constant model with a parameter for continuous 
time, 5C,%- = 	PCO% + β*A + DC,% + FC,%-, which allows a random intercept for each individual and 
a fixed effect of both the exposure and time. 
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Using the first time point 
The first approach to question of whether there is a relationship between exposure and 
outcome is to calculate the correlation between the exposure and site-specific methylation at 
the first time point. Considering only the first time point would reduce the number of tests 
required and thereby the multiple testing problem would be reduced somewhat. 
Additionally, we might think that the methylation from the time point closest to the 
exposure has a unique relationship with it and would want to prioritize effects detectable in 
the first time point. 
We denote this approach as T1 and use it with our two methods: using the False 
Discovery Rate (FDR) method before fitting a linear mixed effects (LME) model or using 
FDR after fitting the LME model. These are denoted T1-FDR and T1-1000 respectively. 
T1-FDR: 
Given the resultant p-values from testing the pairwise correlation between predictor and 
outcome at just the first time point, we use the FDR method to select sites that pass the 
significance threshold (q < 0.05) and fit an LME model to each of these sites. Finally, we 
return the sites with (unadjusted) p < 0.05 from the p-values returned by the LME. 
T1-1000: 
Given the same p-values as in T1-FDR, we do not make any multiple testing correction 
before fitting an LME. Instead, we choose the 1000 lowest p-values to fit to an LME. Once 
we have fit an LME model to the sites, we correct the resultant 1,000 p-values using FDR 
with the number of tests (m in the FDR algorithm) equal to 470,560 and return those that 
achieve the significance threshold. 
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All time points 
Instead of testing a subset of our outcomes, we could use all of our time points, looking 
at the relationship between exposure and outcome for each observation as if they had been 
measured at the same time point. For XC-, where 6 = 1… 470,560 and A = 1, 2, 3, we use all 
values of  XC-. 
 This would prioritize the strong associations because strongly associated loci would 
appear three times. However, because controlling the rate of false discoveries means more 
tests achieve significance when there are a larger number of true associations, this approach 
would allow more power. 
We denote this approach as AT and use it with our two methods as before. 
AT-FDR: 
While the previous approach tested only the first time point, this approach tests pairwise 
correlation on all of the data, tripling the number of tests that are done (Y = 470,560	×3). 
Ignoring the time index, we adjust the resultant p-values using FDR and select those that 
pass the significance threshold (q < 0.05). The perceived benefit of this method is that some 
sites might not achieve significance at the first time point, but would at the second or third. 
We then fit an LME model for each of the selected sites and return the sites with 
(unadjusted) p < 0.05 from the p-values returned by the LME. 
AT-1000: 
This procedure calculates "×	! pairwise correlations as in the AT-FDR, but does not 
adjust the p-values as in the T1-1000. We choose the 1000 lowest p-values from the "×	! 
tests, ignoring the time index. After fitting the selected sites to LME models, we correct the 
resultant p-values using FDR (Y = 470,560) and return those that achieve the significance 
threshold. 
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Table 2: Overview of Selection Approaches 
NAME PROCESS    
T1-FDR ρ T1 → FDR → LME 
AT-FDR ρ all T → FDR → LME 
ET-FDR ρ each T → FDR → LME 
T1-1000 ρ T1 → 1000 LME → FDR 
AT-1000 ρ all T → 1000 LME → FDR 
ET-1000 ρ each T → 1000* LME → FDR 
ALL-LME fit LME → FDR  
*ET-1000 could select up to 3000 values 
Each time point 
Another approach we might take would be to treat the outcomes at each time point as its 
own data set. If we assume that our outcomes are correlated over time, we might be able to 
find some of the weaker associations in one time point but not the others. For XC-, where 6 =1… 470,560 and A = 1, 2, 3, we use the p-values obtained from XC0 and XC* and XCZ. 
Thus we assess the correlations between exposure and outcomes and correct for multiple 
testing within each time point. This will increase our Type I error, but we will find more 
correlations. If the outcome is not stable over time, we would notice that the number of 
associations found is different between time points. 
We denote this approach as ET and use it with our two methods as before. 
ET-FDR: 
This approach tests pairwise correlation on all of the data, as does the previous one, but 
adjusts for multiple testing differently. Here, we test for correlation on all of the data, but 
use the FDR method within each time point (Y = 470,560). We then select the distinct sites 
that pass the significance threshold (q < 0.05), regardless of whether they passed in just one 
time point or all three, and fit these sites to an LME for each site. Finally, we return the sites 
with (unadjusted) p < 0.05 from the p-values returned by the LME.  
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ET-1000: 
This procedure calculates "×	! pairwise correlations as in the ET-FDR method, then 
chooses the 1000 lowest p-values from each of the time points, as in the T1-1000 method, 
resulting in 3000 selections. However, we select only the unique sites, and thus will fit 
between 1000 and 3000 sites to LME models. We correct the resultant p-values using FDR 
and return those that achieve the significance threshold.  
All-LME 
All of the sites are fit with an LME and FDR is used to correct for multiple testing (Y =470,560). 
Applied methods 
Instead of using pairwise correlation tests in the applied analysis, we used robust linear 
regression to assess association at the first time point (Venables & Ripley, 2002). The 
covariates included in the model were maternal glucose, maternal BMI, gestational age, 
maternal college education, parity, smoking during pregnancy, child’s sex, child’s age at time 
of sample collection, and imputed cell counts. To implement this, we used the rlm function 
from the MASS package in R. For the longitudinal analysis, we used robust linear mixed 
effects models from the robustlmm package using a method developed by the author of the 
package (Koller, 2016) with the same covariates as the robust linear regression and the 
addition of a random intercept for each individual. We did not fit random slopes in this 
model, although previous research would suggest this would be beneficial, because three 
time points is relatively few, we had few subjects with all three times observed, and because 
of the computational expense. 
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Batch effects were corrected using ComBat, which uses empirical Bayes to adjust 
experimental variation that has non-biological origins (Johnson, Rabinovic, & Li, 2007), 
from the Bioconductor sva package (Leek, et al., 2017).  
Fitting all 470,870 sites with a robust linear mixed effects model took about 2.25 
minutes per site, or nearly 2 years if run serially. We did initially try ordinary least squares 
regression and linear mixed effects models, which are far less computationally expensive, 
but they found no significant results and were not used in the preliminary analysis that 
motivated this study. 
The preliminary analysis stratified by sex, but we have chosen to use sex as a covariate in 
the model in the interest of both power considerations and computational time. 
Additionally, they used Beta-values in their analysis, but we opted for M-values because 
bounded values are less appropriate for fitting to linear models.  
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CHAPTER 4 
RESULTS 
Figure 1: Percentage Rejected in the Weak Association Group 
 
Simulation Results 
To evaluate our different methods of adjusting for multiple testing, we considered the 
percentage of true associations rejected in each of the weak, moderate, and strong 
association groups; the number of false rejections made by each method; and the positive 
predictive value of each method. 
We found that all methods were similar in their ability to detect associations in the 
strong and moderate association groups. Therefore, we focus on the weak association group 
where there were a total of 500 sites with a true simulated correlation.  
The percentage of true associations found out of the number of true associations is an 
approximation of the simulated power of the test, which is the probability that the test 
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rejects the null hypothesis when the alternative hypothesis is true. However, because 
calculations of power depend on the effect sizes expected and because we did not use 
biologically plausible effect sizes and instead calibrated an effect size based on expected 
power, we cannot consider these measures as power. That is to say, the stipulation of our 
experiment was that we would not expect to be able to detect many of the weakly associated 
sites and we aimed to increase the percentage that we could detect. Therefore, these 
percentages of rejections in the weak association group are approximations of the power 
relative to each other, with the understanding the the T1-FDR method was fixed at ≤ 0.10. 
As seen in Figure 1, the methods that rank the initial p-values and utilize FDR after 
fitting an LME reject the largest percentages of the weakly associated sites. This is true in 
both an attenuated relationship and a constant relationship between predictor and outcome 
over time. The methods that correct with FDR before fitting an LME reject a far smaller 
percentage of sites, while the method of no pre-selection and only fitting an LME is much 
closer to the rank methods. 
Important to note is that under the acute association, the methods that use FDR first 
reject a similar percentage to the attenuated and constant association data models, while the 
rank methods make few rejections and closely resemble the null data model. 
Table 3: Number of False Rejections 
METHOD CONSTANT ATTENUATED ACUTE NULL 
ALL LME 18 12 0 0 
AT-1000 43 37 0 0 
ET-1000 182 123 0 0 
T1-1000 171 119 0 0 
AT-FDR 13 5 2 0 
ET-FDR 14 6 3 0 
T1-FDR 5 5 3 0 
Averaged over 1000 replicates, rounded to the nearest integer. 
 21 
When considering 470,560 possible outcomes, setting an acceptable Type I error of α = 
0.05 would result in 23,528 false rejections. Representing the false rejections we found as a 
percentage would be approximately α = 0.0005, which is difficult to understand practically. 
Therefore, we consider Type I error in terms of the number of false rejections we make by 
method and data model, as seen in Table 3. We found fewer than 50 false rejections for all 
methods except the rank methods that used either the first time point or each time point 
separately. Because we are controlling the false discovery rate, more false rejections are 
allowed when more true rejections are found. 
The positive predictive value (PPV) is the complement of the false discovery rate (FDR) 
and therefore, we would expect to see a consistent value of 95% for all methods if we held the 
FDR at 5%. However, as seen in Figure 2, the rank methods do not control the FDR as well. 
The inflated value for the acute relationship is likely due to the low number of rejections 
made. 
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Pre-selecting with FDR limits the power of the test and performs identically for 
attenuated, constant and acute relationships, but controls Type I error well. Pre-selecting 
with ranked p-values gives more power and differentiates between attenuated/constant and 
acute, but does not control Type I error as well. Testing each site with a linear mixed effects 
model and controlling the FDR has the consistently highest PPV, a low number of false 
positives, and is able to differentiate between differential methylation that was present at 
only one time point vs. a persistent relationship. 
Viva Data Results 
Fitting the robust linear regression with the cord blood and the covariates previously 
mentioned found three sites that had a significant effect of maternal glucose on the 
methylation outcomes after correction with FDR. If we instead fit these three sites to a 
●●
●
●●
●
●●●
65%
75%
85%
95%
100%
Attenuated Constant Acute
Data Generating Assumption
PP
V
Methods
●
●
●
●
●
●
●
All LME
AT−1000
ET−1000
T1−1000
AT−FDR
ET−FDR
T1−FDR
Method Groups
● FDR first
Rank first
All LME
Positive Predictive Value by Method
Figure 2: Positive Predictive Value by Method 
 23 
robust linear mixed effects model, the fixed effect of maternal glucose on the outcome was 
significant with unadjusted p < 0.05. 
Using pairwise tests at the second and third time points yielded more significant sites 
than limiting to the cord blood: our all time points selection method identified 195 sites and 
the method using each time point identified 306. The rank method identified close to the 
maximum number of sites it could. The results are summarized in Table 4 below. 
Table 4: Number of sites selected and significant in the Project Viva cohort 
METHOD SITES SELECTED SITES SIGNIFICANT 
T1-FDR 3 3 
AT-FDR 195 76 
ET-FDR 306 85 
T1-1000 1000 0 
AT-1000 999 0 
ET-1000 2985 0 
ALL-LME  0 
 
All of the rank methods identified no sites significant using the longitudinal analysis and 
analyzing all of the p-values from the different LME models had the same result. The FDR 
methods selected fewer sites, but returned some of them as significant.  
  
 24 
CHAPTER 5 
DISCUSSION 
A key component of testing longitudinal differential epigenetic outcomes is determining 
whether changes persist over time. This is important because assuming that a differential 
outcome is constant over the lifetime of an individual is a very strong assumption and it is 
unknown what functional form an association would take over time. From a pragmatic 
standpoint, it is important to consider that the relationship might not be constant because 
differences that correct themselves would not require interventions or treatments. We also 
consider an attenuated relationship to determine if fitting a constant model to attenuated 
data is an acceptable choice; fitting an attenuated model would require more parameters to 
be fit and decrease the degrees of freedom in the model, which is undesirable. 
Testing for correlation only does not detect whether changes persist over time, thus a 
longitudinal model is necessary. We found that pre-selecting with a correlation test 
diminishes the ability of even a linear mixed effects model to return differential results when 
the data is generated such that an association exists at the first time point but is not present 
in the later time points. This is seen in the percentage of weak association sites found; the all 
LME and rank methods do not find any significant sites in the acute relationship. Because 
the longitudinal model answers the question of whether there is a persistent relationship, it 
should not find significant sites under the acute data generating assumption, given that the 
relationship does not persist. However, the FDR methods reject a similar number of sites 
between constant, attenuated, and acute, which implies that if one uses these methods, the 
results returned could be coming from an acute relationship and we could not distinguish 
this. 
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With regard to our different selection methods, T1, AT and ET, we would assume that 
under the null, ET would select three times as many sites as AT would. This is because if 
there is no relationship, there is not an expectation that sites would be returned as 
significant more than once. Thus, the spuriously significant sites at each time point would 
have little to no overlap with the other time points. In our simulation results, we see that our 
ET-1000 method returns roughly three times more false rejections than AT-1000 under both 
the constant and attenuated assumptions.  
Our applied results in Project Viva suggest that the underlying relationship between 
maternal glucose and a child’s methylation outcomes over time may not be linear. The 
pattern of the number of sites found by each method is similar to that of the simulated acute 
relationship, which suggests that the relationship does not persist over time. Notably, we do 
not select any significant sites with the all LME or rank methods, but we do with the FDR 
methods. However, we cannot rule out a true relationship of some form because we have not 
explored non-linear relationships or other possible functional forms of the relationship. 
Additionally, we did not consider random slopes because we lack sufficient repeated 
measures, but this would be a logical next step. 
This does not imply that maternal glucose levels are not mechanistically involved in 
increasing a child’s risk of obesity or diabetes later in life, nor does it suggest that differential 
methylation is not involved. Rather, it implies that differential methylation in cord blood 
may not be reflected in peripheral blood cells later in life. Differential methylation patterns 
might still exist in other somatic cells in the mechanistic pathways of diabetes. 
While simulation studies put us in a position of omniscience, data analysis comes from a 
position of ignorance.  The question in data analysis is not which procedure to perform, but 
what kind of relationship we are interested in. If we always fit a longitudinal model, we will 
 26 
miss an acute relationship. We might take this to mean that there is no relationship at all, 
but a relationship present in cord blood might persist in other cells, or the relationship 
might take a different form. Thus fitting a longitudinal model is appropriate when the 
question is whether the association persists, but inappropriate if the question is whether 
there is an association at any of the times. However, often we are asking both questions and 
we would recommend that both analyses be performed.  
Therefore, if the research question hinges on whether the association with the exposure 
persists over time, pre-selecting with a correlation test will likely not answer this question 
and a full longitudinal analysis is necessary. We recommend that pairwise tests with the time 
point of interest be conducted separately from the longitudinal analysis, with both pairwise 
and longitudinal fitting all sites. If there are significant results in the first time point and not 
in the longitudinal analysis, it can be concluded that the relationship might not persist. If 
computational resources are limited, fitting a large number of sites selected from all of the 
time points and adjusting the m in an FDR procedure might be an acceptable 
approximation, although the FDR will not be as well-controlled. 
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